한글목차

골암 치료 세계 시장 규모는 2024년 13억 달러에 달할 것으로 예상되며, 예측 기간 동안 2030년까지 CAGR 5.12%의 괄목할 만한 성장을 보일 것으로 예상됩니다.

세계 골암 치료 시장은 광범위한 종양학 분야에서 역동적으로 진화하고 있는 분야입니다. 이 시장은 원발성(뼈에서 발생하는) 또는 이차성(신체의 다른 부위에서 전이된 경우) 골암이 야기하는 고유한 문제를 해결하는 데 초점을 맞추고 있습니다. 이 시장에는 골암의 진단, 관리, 치료 가능성을 목표로 하는 다양한 치료 및 요법이 포함됩니다. 예를 들어, 미국암협회는 2022년에 3,910명의 새로운 골암 환자가 발생하고 2,100명이 사망할 것으로 추정하고 있습니다. 원발성 골암은 드물며 전체 암의 1% 미만입니다. 골육종이 가장 많고 연골육종과 유잉육종이 그 뒤를 잇습니다.

시장 촉진요인

기술 발전

주요 시장 과제

한정된 연구 자금과 조사 자원

주요 시장 동향

표적 치료의 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 골암 치료 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 골암 종류별(원발성 골암, 속발성 골암)
  • 치료 종류별(화학요법, 표적요법, 방사선 치료, 수술, 기타)
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 골암 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 골암 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 골암 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 골암 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 골암 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 이집트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 발매
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• Amgen Inc
• Baxter Inc
• Bayer AG
• ZetaMet technology
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Recordati Group
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Spectrum Pharmaceuticals Inc.

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

영문목차

Global Bone Cancer Treatment Market was valued at USD 1.30 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.12% through 2030. The global bone cancer treatment market is a dynamic and evolving sector within the broader field of oncology. It is dedicated to addressing the unique challenges posed by bone cancers, which can be primary (originating in the bone) or secondary (resulting from metastasis from other parts of the body). This market encompasses a wide range of treatments and therapies aimed at diagnosing, managing, and potentially curing bone cancer. For instance, the American Cancer Society estimated 3,910 new bone cancer cases and 2,100 deaths in 2022. Primary bone cancers are rare, comprising less than 1% of all cancers. Osteosarcoma is the most common type, followed by chondrosarcoma and Ewing sarcomas.

Key Market Drivers

Technological Advancements

Technological advancements have played a pivotal role in reshaping the landscape of bone cancer treatment. Modern imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, have revolutionized the diagnosis and staging of bone cancer. These technologies offer unparalleled precision in locating and characterizing tumors, enabling healthcare professionals to make informed decisions about treatment. One of the most significant breakthroughs in bone cancer treatment is the development of targeted therapies. Unlike traditional chemotherapy, which affects both cancerous and healthy cells, targeted therapies focus on specific molecules or pathways within cancer cells. This precision minimizes collateral damage to healthy tissues and reduces the side effects associated with treatment. Technological advancements have also led to the refinement of surgical procedures for bone cancer treatment. Minimally invasive techniques, such as robotic-assisted surgery and laparoscopy, allow for smaller incisions, faster recovery times, and reduced postoperative pain. The emergence of 3D printing technology has transformed the creation of customized prosthetics for bone cancer survivors. These prosthetics are tailored to fit each patient's unique anatomy, providing a higher level of comfort and functionality. This innovation significantly improves the quality of life for individuals who have undergone limb-sparing surgeries.

Key Market Challenges

Limited Research Funding and Resources

One significant challenge faced by the bone cancer treatment market is the relative rarity of bone cancer compared to other types of cancer, such as breast or lung cancer. Because of its lower prevalence, bone cancer research often receives fewer resources and funding allocations. This limitation can impede the development of innovative treatments and therapies specifically tailored to bone cancer. Conducting clinical trials and research related to bone cancer can be financially demanding. The costs associated with patient recruitment, data collection, and the development of new drugs or treatment modalities are substantial. Inadequate funding and resources can hinder the progress of clinical trials and limit the exploration of potential breakthroughs.

Key Market Trends

Advancements in Targeted Therapies

One significant trend in the global bone cancer treatment market is the rapid development of targeted therapies. Rather than employing broad-spectrum treatments like chemotherapy, precision medicine is gaining prominence. This approach involves identifying specific genetic mutations or molecular markers unique to an individual's cancer cells. Targeted therapies are designed to precisely target these markers, disrupting the growth and spread of cancer cells while sparing healthy tissues. This trend is improving treatment outcomes and reducing the side effects associated with traditional therapies. Immunotherapy is another burgeoning trend in bone cancer treatment. This approach harnesses the body's immune system to recognize and attack cancer cells. Immunotherapeutic drugs, such as immune checkpoint inhibitors, are being investigated for their potential to enhance the immune response against bone cancer. The development of personalized immunotherapies tailored to each patient's unique immune profile is on the horizon, offering promising avenues for treatment.

Key Market Players

• Amgen Inc
• Baxter Inc
• Bayer AG
• ZetaMet Technology
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Recordati Group
• Takeda Pharmaceutical Company
• Eli Lilly and Company
• Spectrum Pharmaceuticals Inc

Report Scope:

In this report, the Global Bone Cancer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Cancer Treatment Market, By Bone Cancer Type:

• Primary Bone Cancer
• Secondary Bone Cancer

Bone Cancer Treatment Market, By Treatment Type:

• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Surgery
• Others

Bone Cancer Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bone Cancer Treatment Market.

Available Customizations:

Global Bone Cancer Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Bone Cancer Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Bone Cancer Type (Primary Bone Cancer, Secondary Bone Cancer)
  • 5.2.2. By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Surgery, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Bone Cancer Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Bone Cancer Type
  • 6.2.2. By Treatment Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone Cancer Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Bone Cancer Type
      • 6.3.1.2.2. By Treatment Type
  • 6.3.2. Mexico Bone Cancer Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Bone Cancer Type
      • 6.3.2.2.2. By Treatment Type
  • 6.3.3. Canada Bone Cancer Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Bone Cancer Type
      • 6.3.3.2.2. By Treatment Type

7. Europe Bone Cancer Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Bone Cancer Type
  • 7.2.2. By Treatment Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bone Cancer Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Bone Cancer Type
      • 7.3.1.2.2. By Treatment Type
  • 7.3.2. Germany Bone Cancer Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Bone Cancer Type
      • 7.3.2.2.2. By Treatment Type
  • 7.3.3. United Kingdom Bone Cancer Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Bone Cancer Type
      • 7.3.3.2.2. By Treatment Type
  • 7.3.4. Italy Bone Cancer Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Bone Cancer Type
      • 7.3.4.2.2. By Treatment Type
  • 7.3.5. Spain Bone Cancer Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Bone Cancer Type
      • 7.3.5.2.2. By Treatment Type

8. Asia-Pacific Bone Cancer Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Bone Cancer Type
  • 8.2.2. By Treatment Type
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bone Cancer Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Bone Cancer Type
      • 8.3.1.2.2. By Treatment Type
  • 8.3.2. India Bone Cancer Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Bone Cancer Type
      • 8.3.2.2.2. By Treatment Type
  • 8.3.3. South Korea Bone Cancer Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Bone Cancer Type
      • 8.3.3.2.2. By Treatment Type
  • 8.3.4. Japan Bone Cancer Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Bone Cancer Type
      • 8.3.4.2.2. By Treatment Type
  • 8.3.5. Australia Bone Cancer Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Bone Cancer Type
      • 8.3.5.2.2. By Treatment Type

9. South America Bone Cancer Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Bone Cancer Type
  • 9.2.2. By Treatment Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bone Cancer Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Bone Cancer Type
      • 9.3.1.2.2. By Treatment Type
  • 9.3.2. Argentina Bone Cancer Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Bone Cancer Type
      • 9.3.2.2.2. By Treatment Type
  • 9.3.3. Colombia Bone Cancer Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Bone Cancer Type
      • 9.3.3.2.2. By Treatment Type

10. Middle East and Africa Bone Cancer Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Bone Cancer Type
  • 10.2.2. By Treatment Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bone Cancer Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Bone Cancer Type
      • 10.3.1.2.2. By Treatment Type
  • 10.3.2. Saudi Arabia Bone Cancer Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Bone Cancer Type
      • 10.3.2.2.2. By Treatment Type
  • 10.3.3. UAE Bone Cancer Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Bone Cancer Type
      • 10.3.3.2.2. By Treatment Type
  • 10.3.4. Egypt Bone Cancer Treatment Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Bone Cancer Type
      • 10.3.4.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenge

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Amgen Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysi
• 14.2. Baxter Inc
• 14.3. Bayer AG
• 14.4. ZetaMet technology
• 14.5. Johnson & Johnson
• 14.6. Novartis AG
• 14.7. Pfizer Inc.
• 14.8. Recordati Group
• 14.9. Takeda Pharmaceutical Company
• 14.10. Eli Lilly and Company
• 14.11. Spectrum Pharmaceuticals Inc.

15. Strategic Recommendations

16. About Us & Disclaimer